Status:

NOT_YET_RECRUITING

Hodgkin's Disease and Chemotherapy Before 40 Years

Lead Sponsor:

Lille Catholic University

Conditions:

Hodgkin Disease

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

A few studies have focused on other solid cancers (colorectal, prostate). On the other hand, the study of cognitive impairment in Hodgkin's disease remains less developed, and structural and functiona...

Detailed Description

Hodgkin's disease is a neoplasia of lymphoid tissue characterized by the characteristic presence of Reed Sternberg cells. This disease is preferentially affecting young patients under the age of 40. I...

Eligibility Criteria

Inclusion

  • Inclusion criteria - case :
  • Patient with newly diagnosed Hodgkin's disease
  • With intention to treat with chemotherapy +/- radiotherapy
  • Aged between 18 and 40 years
  • Fluency in French
  • Able to undergo neuropsychological evaluation (absence of major sensory disorders)
  • Agreeing to take part in the study and having signed the informed consent form
  • Affiliated with a social security scheme
  • Inclusion criteria - controls:
  • Individual without Hodgkin's disease
  • Aged between 18 and 40
  • Proficient in French
  • Agreeing to participate in the study and having signed the informed consent form
  • Affiliated with a social security scheme
  • Cases and controls will be matched on age (± 5 years difference), and number of years of education (difference ≤ 2 years).
  • Non-inclusion criteria - cases + controls :
  • Claustrophobia preventing MRI from being performed
  • Contraindication to MRI
  • Previous chemotherapy
  • History of neurological or psychiatric illness, including severe depression, or cognitive impairment
  • Use of medications that may cause neurological or psychiatric signs
  • Alcohol or drug abuse
  • Pregnant women
  • Persons under guardianship or trusteeship

Exclusion

    Key Trial Info

    Start Date :

    May 15 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 1 2028

    Estimated Enrollment :

    63 Patients enrolled

    Trial Details

    Trial ID

    NCT06116929

    Start Date

    May 15 2024

    End Date

    January 1 2028

    Last Update

    February 28 2024

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Centre Hospitalier Artois Ternois

    Arras, France

    2

    Hôpital Claude Huriez

    Lille, France

    3

    Hôpital Saint-Philibert

    Lomme, France

    4

    Hôpital Victor Provo

    Roubaix, France